Nighttime fasting may decrease breast cancer risk in women
the ONA take:
According to a recent study published in the journal Cancer Epidemiology, Biomarkers & Prevention, researchers from the University of California, San Diego School of Medicine have found that a reduction in the amount of time spent eating and an increase in overnight fasting decreases glucose levels and may lower the risk of breast cancer among women.
In the study, participants reported eating five times per day with an average fasting of 12 hours during the nighttime. Women who reported longer fasting periods also consumed fewer calories during the day, ate fewer calories after 10 p.m, and had a fewer eating episodes.
Results showed that women who had a longer fasting duration overnight had significantly better glycemic control. In addition, researchers found that each 3 hour increase in overnight fasting was associated with a 4% lower postprandial glucose level.
The researchers note that larger studies are needed to confirm that overnight fasting improves glycemic control and reduces breast cancer risk.
An increase in overnight fasting decreases glucose levels and may lower the risk of breast cancer among women.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- MRD Negativity Associated With Prolonged Survival in Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|